Dobutamine stress echocardiography for detection and assessment of coronary artery disease

Department of Medicine (Clinical Cardiology), Hammersmith Hospital, London, England.

Stress echocardiography with dobutamine infusion for detection of coronary artery disease is a potential alternative to exercise stress testing with some theoretic advantages. Fifty patients who were not receiving cardioactive medication were prospectively studied with two-dimensional echocardiography and 12-lead electrocardiography (ECG) during incremental dobutamine infusion (5, 10, 15 and 20 micrograms/kg body weight per min, each dose for 8 min). Images were analyzed by using an 11-segment left ventricular model. All patients underwent correlative exercise ECG and coronary angiography, which revealed normal coronary arteries in 14 and significant disease (greater than or equal to 70% diameter stenosis) in 36. Peak rate-pressure product during dobutamine infusion was 18,845 +/- 4,156 versus 23,740 +/- 6,158 mm Hg/min on exercise (p less than 0.01). Interobserver concordance for wall motion analysis was good (kappa coefficient = 0.77). The use of baseline (n = 14) or reversible (n = 24) regional asynergy to define an abnormal dobutamine echocardiogram resulted in a sensitivity for detecting coronary artery disease of 78% and a specificity of 93%. Corresponding data for the dobutamine ECG were 47% and 71% and for the exercise ECG were 72% and 71%, respectively. The development of new mitral regurgitation on Doppler color flow imaging (n = 4) improved sensitivity to 81% without loss of specificity. Inducible asynergy or new mitral regurgitation was observed in 6 (50%) of 12 patients with single-, 6 (60%) of 10 with double- and 12 (86%) of 14 with triple-vessel disease. The site of transient asynergy provided additional localizing information. Exercise duration and time to diagnostic ST segment shift were shorter in patients with coronary artery disease with versus those without echocardiographic evidence of ischemia (both p less than 0.05). Side effects during dobutamine infusion were mild and short-lived. Dobutamine stress echocardiography is well tolerated, is useful for detection and assessment of coronary artery disease and is applicable to patients unable to exercise.

This article has been cited by other articles:

				R. Sicari, P. Nihoyannopoulos, A. Evangelista, J. Kasprzak, P. Lancellotti, D. Poldermans, J.-U. Voigt, J. L. Zamorano, and on behalf of the European Association of Echocardi Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC) Eur J Echocardiogr, July 1, 2008; 9(4): 415 - 437. [Abstract] [Full Text] [PDF]

				Y. Matsumura, T. Hozumi, K. Arai, K. Sugioka, K. Ujino, Y. Takemoto, H. Yamagishi, M. Yoshiyama, and J. Yoshikawa Non-invasive assessment of myocardial ischaemia using new real-time three-dimensional dobutamine stress echocardiography: comparison with conventional two-dimensional methods Eur. Heart J., August 2, 2005; 26(16): 1625 - 1632. [Abstract] [Full Text] [PDF]

				R. Florenciano-Sanchez, G. de la Morena-Valenzuela, M. Villegas-Garcia, F. Soria-Arcos, R. Rubio-Paton, F. Teruel-Carrillo, J. Hurtado, and M. Valdes-Chavarri Noninvasive assessment of coronary flow velocity reserve in left anterior descending artery adds diagnostic value to both clinical variables and dobutamine echocardiography: a study based on clinical practice Eur J Echocardiogr, August 1, 2005; 6(4): 251 - 259. [Abstract] [Full Text] [PDF]

				Y. Ichikawa, H. Sakuma, N. Suzawa, K. Kitagawa, K. Makino, T. Hirano, and K. Takeda Late gadolinium-enhanced magnetic resonance imaging in acute and chronic myocardial infarction: Improved prediction of regional myocardial contraction in the chronic state by measuring thickness of nonenhanced myocardium J. Am. Coll. Cardiol., March 15, 2005; 45(6): 901 - 909. [Abstract] [Full Text] [PDF]

				E. Barbato, J. Bartunek, E. Wyffels, W. Wijns, G. R. Heyndrickx, and B. De Bruyne Effects of intravenous dobutamineon coronary vasomotion in humans J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1596 - 1601. [Abstract] [Full Text] [PDF]

				M. J. Kern Dobutamine and the coronary vasomotion paradox J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1602 - 1604. [Full Text] [PDF]

				M. D. Cheitlin, W. F. Armstrong, G. P. Aurigemma, G. A. Beller, F. Z. Bierman, J. L. Davis, P. S. Douglas, D. P. Faxon, L. D. Gillam, T. R. Kimball, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American college of cardiology/American heart association task force on practice guidelines (ACC/AHA/ASE committee to update the 1997 guidelines for the clinical application of echocardiography) J. Am. Coll. Cardiol., September 3, 2003; 42(5): 954 - 970. [Full Text] [PDF]

				M. D. Cheitlin, W. F. Armstrong, G. P. Aurigemma, G. A. Beller, F. Z. Bierman, J. L. Davis, P. S. Douglas, D. P. Faxon, L. D. Gillam, T. R. Kimball, et al. ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography) Circulation, September 2, 2003; 108(9): 1146 - 1162. [Full Text] [PDF]

				P. Ammann, M. Maggiorini, O. Bertel, E. Haenseler, H. I. Joller-Jemelka, E. Oechslin, E. I. Minder, H. Rickli, and T. Fehr Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes J. Am. Coll. Cardiol., June 4, 2003; 41(11): 2004 - 2009. [Abstract] [Full Text] [PDF]

				E. Barnes, R. J. C. Hall, D. P. Dutka, and P. G. Camici Absolute blood flow and oxygenconsumption in stunned myocardiumin patients with coronary artery disease J. Am. Coll. Cardiol., February 6, 2002; 39(3): 420 - 427. [Abstract] [Full Text] [PDF]

				M. Ahmad, T. Xie, M. McCulloch, G. Abreo, and M. Runge Real-time three-dimensional dobutamine stress echocardiography in assessment of ischemia: comparison with two-dimensional dobutamine stress echocardiography J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1303 - 1309. [Abstract] [Full Text] [PDF]

				S. C. Smart, A. Bhatia, R. Hellman, T. Stoiber, A. Krasnow, B. D. Collier, and K. B. Sagar Dobutamine-atropine stress echocardiography and dipyridamole sestamibi scintigraphy for the detection of coronary artery disease: limitations and concordance J. Am. Coll. Cardiol., October 1, 2000; 36(4): 1265 - 1273. [Abstract] [Full Text] [PDF]

				E Barnes, C S R Baker, D P Dutka, O Rimoldi, C A Rinaldi, P Nihoyannopoulos, P G Camici, and R J C Hall Prolonged left ventricular dysfunction occurs in patients with coronary artery disease after both dobutamine and exercise induced myocardial ischaemia Heart, March 1, 2000; 83(3): 283 - 289. [Abstract] [Full Text]

				K. O. Akosah, B. Denlinger, and P. K. Mohanty Safety Profile and Hemodynamic Responses to {beta}-Adrenergic Stimulation by Dobutamine in Heart Transplant Patients* Chest, December 1, 1999; 116(6): 1587 - 1592. [Abstract] [Full Text] [PDF]

				W. G. Hundley, C. A. Hamilton, M. S. Thomas, D. M. Herrington, T. B. Salido, D. W. Kitzman, W. C. Little, and K. M. Link Utility of Fast Cine Magnetic Resonance Imaging and Display for the Detection of Myocardial Ischemia in Patients Not Well Suited for Second Harmonic Stress Echocardiography Circulation, October 19, 1999; 100(16): 1697 - 1702. [Abstract] [Full Text] [PDF]

				R. Hoffmann, H. Lethen, H. Kuhl, W. Lepper, and P. Hanrath Extent and severity of test positivity during dobutamine stress echocardiography. Influence on the predictive value for coronary artery disease Eur. Heart J., October 2, 1999; 20(20): 1485 - 1492. [Abstract] [PDF]

				K.-C. Hung, F.-C. Lin, M.-S. Chern, H.-J. Chang, I.-C. Hsieh, and D. Wu Mechanisms and clinical significance of transient atrioventricular block during dobutamine stress echocardiography J. Am. Coll. Cardiol., October 1, 1999; 34(4): 998 - 1004. [Abstract] [Full Text] [PDF]

				G. Fragasso, C. Lu, P. Dabrowski, P. Pagnotta, I. Sheiban, and S. L. Chierchia Comparison of stress/rest myocardial perfusion tomography, dipyridamole and dobutamine stress echocardiography for the detection of coronary disease in hypertensive patients with chest pain and positive exercise test J. Am. Coll. Cardiol., August 1, 1999; 34(2): 441 - 447. [Abstract] [Full Text] [PDF]

				J. Bartunek, W. Wijns, G. R. Heyndrickx, and B. de Bruyne Effects of Dobutamine on Coronary Stenosis Physiology and Morphology : Comparison With Intracoronary Adenosine Circulation, July 20, 1999; 100(3): 243 - 249. [Abstract] [Full Text] [PDF]

				A. M. Garber and N. A. Solomon Cost-Effectiveness of Alternative Test Strategies for the Diagnosis of Coronary Artery Disease Ann Intern Med, May 4, 1999; 130(9): 719 - 728. [Abstract] [Full Text] [PDF]

				J. F. Lewis, L. Lin, S. McGorray, C. J. Pepine, M. Doyle, D. Edmundowicz, R. Holubkov, G. Pohost, N. Reichek, W. Rogers, et al. Dobutamine stress echocardiography in women with chest pain: Pilot phase data from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE) J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1462 - 1468. [Abstract] [Full Text] [PDF]

				C.-Y. Lee, P. A. Pellikka, R. B. McCully, D. W. Mahoney, and J. B. Seward Nonexercise stress transthoracic echocardiography: transesophageal atrial pacing versus dobutamine stress J. Am. Coll. Cardiol., February 1, 1999; 33(2): 506 - 511. [Abstract] [Full Text] [PDF]

				J A S. Román, I Vilacosta, J A Castillo, M J Rollán, M Hernández, V Peral, I Garcimartín, M d. M. de la Torre, and F Fernández-Avilés Selection of the optimal stress test for the diagnosis of coronary artery disease Heart, October 1, 1998; 80(4): 370 - 376. [Abstract] [Full Text]

				R. L. Larsen, P. M. Applegate, D. A. Dyar, P. A. Ribeiro, S. D. Fritzsche, N. F. Mulla, G. S. Shirali, M. A. Kuhn, R. E. Chinnock, and P. M. Shah Dobutamine stress echocardiography for assessing coronary artery disease after transplantation in children J. Am. Coll. Cardiol., August 1, 1998; 32(2): 515 - 520. [Abstract] [Full Text] [PDF]

				S.-C. Chuah, P. A. Pellikka, V. L. Roger, R. B. McCully, and J. B. Seward Role of Dobutamine Stress Echocardiography in Predicting Outcome in 860 Patients With Known or Suspected Coronary Artery Disease Circulation, April 21, 1998; 97(15): 1474 - 1480. [Abstract] [Full Text] [PDF]

				R S Khattar, R Senior, and A Lahiri Assessment of myocardial perfusion and contractile function by inotropic stress Tc-99m sestamibi SPECT imaging and echocardiography for optimal detection of multivessel coronary artery disease Heart, March 1, 1998; 79(3): 274 - 280. [Abstract] [Full Text]

				M. D. Cheitlin, J. S. Alpert, W. F. Armstrong, G. P. Aurigemma, G. A. Beller, F. Z. Bierman, T. W. Davidson, J. L. Davis, P. S. Douglas, L. D. Gillam, et al. ACC/AHA Guidelines for the Clinical Application of Echocardiography : A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography) Developed in Collaboration With the American Society of Echocardiography Circulation, March 18, 1997; 95(6): 1686 - 1744. [Full Text]

				K. A. Connors Does the Use of Atro pine Provide Additional Ischemlic Stimulus to Myocardiumi During Dobutamline Stress Echocardiography? Journal of Diagnostic Medical Sonography, November 1, 1996; 12(6): 254 - 259. [Abstract] [PDF]

				J. A. Panza, V. Dilsizian, J. M. Laurienzo, R. V. Curiel, and P. T. Katsiyiannis Relation Between Thallium Uptake and Contractile Response to Dobutamine : Implications Regarding Myocardial Viability in Patients With Chronic Coronary Artery Disease and Left Ventricular Dysfunction Circulation, February 15, 1995; 91(4): 990 - 998. [Abstract] [Full Text]

				K. M. Choi, R. J. Kim, G. Gubernikoff, J. D. Vargas, M. Parker, and R. M. Judd Transmural Extent of Acute Myocardial Infarction Predicts Long-Term Improvement in Contractile Function Circulation, September 4, 2001; 104(10): 1101 - 1107. [Abstract] [Full Text] [PDF]